Anti-nephrin antibodies are not enriched in patients with primary and post-transplant recurrent podocytopathies

Francesco Pecoraro; Luca Perico; Federica Casiraghi; Paola Rizzo; Matias Trillini; Andrea Angeletti; Manuel Alfredo Podestà; Xhuliana Kajana; Agnese Spennacchio; Marta Todeschini; Marilena Mister; Giuseppe Castellano; Ariela Benigni; Giuseppe Remuzzi

doi:10.1172/JCI204727

Anti-nephrin antibodies are not enriched in patients with primary and post-transplant recurrent podocytopathies

Francesco Pecoraro,¹ Luca Perico,¹ Federica Casiraghi,¹ Paola Rizzo,¹ Matias Trillini,² Andrea Angeletti,³ Manuel Alfredo Podestà,⁴ Xhuliana Kajana,³ Agnese Spennacchio,³ Marta Todeschini,¹ Marilena Mister,¹ Giuseppe Castellano,⁴ Ariela Benigni,¹ and Giuseppe Remuzzi¹

Published April 28, 2026 - More info

View PDF

Abstract

BACKGROUND. Anti-nephrin autoantibodies have emerged as a putative pathogenic driver in a subset of patients with podocytopathies, including those with post-transplant disease recurrence.

METHODS. We measured anti-nephrin autoantibodies in a cohort of 65 patients with podocytopathy associated with steroid-sensitive nephrotic syndrome (n = 39) and steroid-resistant nephrotic syndrome (n = 26), and in 34 patients with post-transplant podocytopathy recurrence. Fourteen patients with membranous nephropathy and 20 healthy volunteers served as controls. ELISA and immunoprecipitation assays were performed to detect anti-nephrin IgG using two different recombinant human nephrin proteins. Immunofluorescence analysis was performed to assess the deposition of IgG and their colocalization with nephrin in renal biopsies.

RESULTS. When using murine antigen-based ELISA, the highest positivity was found in healthy volunteers (55%), correlating with levels of circulating natural anti-α-galactose-α-1,3-galactose antibodies. This cross-reactivity was abrogated with recombinant human nephrin expressed in human cells. In this setting, very low prevalence (<5%) of anti-nephrin antibody-positive patients was found in steroid-sensitive and steroid-resistant nephrotic syndrome cohorts and in patients with post-transplant disease recurrence. These frequencies were comparable to healthy volunteers. Using confocal and super-resolution microscopy, only trace amounts of IgM, but no IgG, were found in the glomeruli of analyzed biopsies, which did not colocalize with nephrin.

CONCLUSIONS. With the methodology presented here, anti-nephrin reactivity was extremely rare and occurred at comparably low frequencies in healthy controls, native-kidney podocytopathies, and post-transplant disease recurrence. This suggests that these autoantibodies are not inherently disease-specific and may not serve as a broad biomarker across podocytopathies.

TRIAL REGISTRATION. ClinicalTrials.gov NCT06334692.

FUNDING. Private donation.

Anti-nephrin antibodies are not enriched in patients with primary and post-transplant recurrent podocytopathies

Francesco Pecoraro,¹ Luca Perico,¹ Federica Casiraghi,¹ Paola Rizzo,¹ Matias Trillini,² Andrea Angeletti,³ Manuel Alfredo Podestà,⁴ Xhuliana Kajana,³ Agnese Spennacchio,³ Marta Todeschini,¹ Marilena Mister,¹ Giuseppe Castellano,⁴ Ariela Benigni,¹ and Giuseppe Remuzzi¹

Article tools

Metrics

Go to

Anti-nephrin antibodies are not enriched in patients with primary and post-transplant recurrent podocytopathies

Francesco Pecoraro,1 Luca Perico,1 Federica Casiraghi,1 Paola Rizzo,1 Matias Trillini,2 Andrea Angeletti,3 Manuel Alfredo Podestà,4 Xhuliana Kajana,3 Agnese Spennacchio,3 Marta Todeschini,1 Marilena Mister,1 Giuseppe Castellano,4 Ariela Benigni,1 and Giuseppe Remuzzi1

Article tools

Metrics

Go to

Sign up for email alerts

Francesco Pecoraro,¹ Luca Perico,¹ Federica Casiraghi,¹ Paola Rizzo,¹ Matias Trillini,² Andrea Angeletti,³ Manuel Alfredo Podestà,⁴ Xhuliana Kajana,³ Agnese Spennacchio,³ Marta Todeschini,¹ Marilena Mister,¹ Giuseppe Castellano,⁴ Ariela Benigni,¹ and Giuseppe Remuzzi¹